ABHD5 and colorectal carcinoma: (3) Notably, ABHD5 might not be easily targeted in the treatment of CRC because of a deficiency of ABHD5 in cancer-cell-potentiated metastasis18, whereas overexpression of ABHD5 in TAMs promoted tumour growth in the present study.